0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 1-20 of 91 Articles
Editorial 
June K. Robinson, MD; Jeffrey P. Callen, MD
Harmonization of types of articles across the 10 journals of The JAMA Network provides an opportunity for JAMA Dermatology to adopt formats that were very well received by readers of other journals. JAMA led the development of the clinical evidence synopsis with the intention of providing a clinically relevant brief ...
Editorial 
Monika Janda, PhD; Anna Finnane, PhD; H. Peter Soyer, MD, FACD
Early diagnosis of melanoma leads to the best prognosis for patients and may be more likely achieved when those who are at high risk for melanoma undergo regular and systematic monitoring. However, many people rarely or never see a dermatologist. Risk prediction models (recently reviewed by Usher-Smith et al1) could ...
Editorial 
A. Shadi Kourosh, MD; Joseph C. Kvedar, MD
Nearly 50 years ago, Kligman1 challenged our field to produce devices and methodologies that would allow dermatologists to care for patients without need of the human eye. Now, as new smartphone applications (apps) spring up daily and new modalities for remote monitoring offer alternatives for managing aspects of the traditional ...
Original Investigation 
Xinyuan Wu, BA; Susan A. Oliveria, ScD; Sarah Yagerman, MD; Lucy Chen, MD; Jennifer DeFazio, MD; Ralph Braun, MD; Ashfaq A. Marghoob, MD

Importance  Patient-driven mobile teledermoscopy may be applicable for monitoring of skin lesions.

Objective  To assess the feasibility, efficacy, and patient receptivity of teledermoscopy for short-term monitoring of clinically atypical nevi.

Design, Setting, and Participants  This was a prospective cohort study performed at an institutional referral ...

Original Investigation 
David B. Buller, PhD; Marianne Berwick, PhD; Kathy Lantz, PhD; Mary Klein Buller, MA; James Shane, BA; Ilima Kane, MA; Xia Liu, MA
Includes: Supplemental Content

Importance  Mobile smartphones are rapidly emerging as an effective means of communicating with many Americans. Using mobile applications (apps), they can access remote databases, track time and location, and integrate user input to provide tailored health information.

Objective  A smartphone mobile app providing personalized, real-time sun ...

Original Investigation 
David B. Buller, PhD; Marianne Berwick, PhD; Kathy Lantz, PhD; Mary Klein Buller, MA; James Shane, BA; Ilima Kane, MA; Xia Liu, MA
Includes: Supplemental Content

Importance  Mobile applications on smartphones can communicate a large amount of personalized, real-time health information, including advice on skin cancer prevention, but their effectiveness may be affected by whether recipients can be convinced to use them.

Objective  To evaluate a smartphone mobile application (Solar Cell) delivering ...

JAMA Dermatology Clinical Evidence Synopsis 
Helena Kastarinen, MD, PhD; Enembe O. Okokon, MD, MSc; Jos H. Verbeek, MD, PhD

Clinical Question  Are there differences in effectiveness between topical anti-inflammatory treatments (steroids, calcineurin inhibitors, or lithium salts) and placebo or azoles in the treatment of seborrheic dermatitis of the face and scalp in adults?

Bottom Line  The topical anti-inflammatory treatments were more effective in achieving total ...

JAMA Dermatology Clinicopathological Challenge 
Kathleen Ann Long, MS; Kara Braudis, MD; Brandon Brown, MD
In this case report, a woman with a history of systemic lupus erythematosus presented with tender erythematous nodules after undergoing right knee arthroscopy. Physical examination revealed poorly demarcated erythematous plaques and nodules, tender to palpation, adjacent to arthroscopy sites. Lesions around the suture sites appeared more violaceous. What is the ...
Observation 
Julia M. Kwan, MD
Mandibuloacral dysplasia (MAD) type B is a rare genodermatosis with early-onset dermatologic, skeletal, and craniofacial abnormalities and long-term renal morbidity.
Viewpoint 
Jason P. Lott, MD, MHS, MSHP; Michael W. Piepkorn, MD, PhD; Joann G. Elmore, MD, MPH
More than 4 decades have passed since the call for “giving patients their medical records” was first proposed to increase patient engagement in health care delivery.1 Today, this vision—once considered radical—is quickly becoming reality, with millions of Americans routinely accessing their medical records through web-based patient portals.1
Original Investigation 
Kevin A. Fajardo, MD, MPH, MTMH; Patrick Keller, MD, MPH; Todd Kobayashi, MD; Chad M. Hivnor, MD; Bryant J. Webber, MD, MPH; Susan P. Federinko, MD, MPH; Juste Tchandja, PhD

Importance  This observational study characterizes a new clinical condition identified in 55 military trainees.

Objective  To determine the incidence and underlying cause of bilateral lower extremity inflammatory lymphedema in Air Force basic trainees.

Design, Setting, and Participants  An observational study was conducted at Lackland Air ...

Case Report/Case Series 
Jean-Marie Tan, MB, BCh, BAO (Hons); Lynlee L. Lin, BSc; Duncan Lambie, BDSc, MBBS, FRCPA; Ross Flewell-Smith, BCom, BEng; Kasturee Jagirdar, MSc; Helmut Schaider, MD; Richard A. Sturm, PhD; Tarl W. Prow, BS, MSc, PhD; H. Peter Soyer, MD, FACD
Includes: Supplemental Content

Importance  The BRAF V600E mutation accounts for the majority of BRAF mutations found in cutaneous melanoma and is also commonly found in nevi. We used dermoscopy-targeted sampling and a microbiopsy device coupled with DNA sequence analysis to highlight BRAF V600E heterogeneity within a multicomponent melanocytic proliferation. This ...

JAMA Dermatology Clinicopathological Challenge 
Tahmina Mahmood, BS; Mary Horner, MD; Alan Menter, MD
Observation 
Vanessa Gargallo, MD; Lara Angulo, MD; Eduardo Hernández, MD, PhD; José Luis Peralto, MD, PhD; Carlos Zarco, MD, PhD
Patients undergoing dialysis are unable to properly eliminate β2-microglobulin, a component of major histocompatibility complex, type 1, which is catabolized in the kidney. Accumulation of β2-microglobulin favors the formation of amyloid, the deposition of which causes dialysis-related amyloidosis (DRA). Symptoms are initially osteoarticular, but progression of the disease involves systemic ...
Comment & Response 
Thierry Passeron, MD, PhD
To the Editor I read with great interest the study by Lim et al1 on the use of afamelanotide in combination with narrowband UV-B for treating vitiligo. So far, there is no truly satisfactory treatment for vitiligo, so any new approach is most welcome. However, this study raises several issues. ...
Comment & Response 
Henry W. Lim, MD; Pearl E. Grimes, MD; Mark Lebwohl, MD
In reply On behalf of all coauthors, we would like to thank Dr Passeron for his interest in our publication.1 We agree with the statement that because the melanogenic effect of afamelanotide requires the presence of melanocortin-1 receptor (MC1R), stimulation of melanoblast differentiation by phototherapy is required. This very point ...
Viewpoint 
Kenneth A. Katz, MD, MSc, MSCE
“Half of what we’re teaching you is wrong,” one of my medical school deans would often say. “The problem,” he would continue, “is that we don’t know which half.”
Editorial 
Peggy A. Wu, MD, MPH; Robert S. Stern, MD
Among white non-Hispanics older than 50 years, nonmelanoma skin cancer (NMSC) incidence is likely to exceed 3.5 million annually in the United States.1 From a clinical and public health perspective, identifying the characteristics of those at the highest risk would allow allocating limited resources to screen those most at need. ...
Original Investigation 
Mackenzie R. Wehner, MD; Eleni Linos, MD, DrPH; Rupa Parvataneni, MS; Sarah E. Stuart, BA; W. John Boscardin, PhD; Mary-Margaret Chren, MD
Includes: Supplemental Content

Importance  Patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) (often termed nonmelanoma skin cancer or keratinocyte carcinoma [KC]) often develop new KCs, but information is limited on the frequency and timing of these subsequent tumors. This information is crucial to guide follow-up care....

Original Investigation 
Hanna Eriksson, MD, PhD; Abdlsattar Zebary, MD, PhD; Ismini Vassilaki, MD; Katarina Omholt, PhD; Mehran Ghaderi, PhD; Johan Hansson, MD, PhD
Includes: Supplemental Content

Importance  BRAFV600E mutations are present in approximately 50% of cutaneous malignant melanomas (CMMs). The use of BRAFV600E mutation–specific monoclonal antibody VE1 immunohistochemical analysis may facilitate rapid detection of BRAFV600E mutations in CMMs and demonstrate heterogeneity among tumors.

Objectives  To characterize the pattern of ...

Sign in to download this free article PDF

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal